Ohio Public Employees Retirement System (OPERS)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,414
Closed -$168K 2044
2022
Q4
$168K Sell
4,414
-1,002
-19% -$34.5K ﹤0.01% 1417
2022
Q3
$136K Buy
+5,416
New +$150K ﹤0.01% 1555
2021
Q2
Sell
-13,888
Closed -$1.39M 2021
2021
Q1
$1.39M Buy
13,888
+2,078
+18% +$242K 0.01% 1158
2020
Q4
$1.46M Buy
11,810
+1,156
+11% +$152K 0.01% 1096
2020
Q3
$1.04M Buy
10,654
+1,614
+18% +$202K 0.01% 1091
2020
Q2
$1.41M Buy
+9,040
New +$1.37M 0.01% 1041

Other funds holding RETA

Ohio Public Employees Retirement System (OPERS)'s RETA Position: Q1 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2023, closing a stake of 4,414 shares — an estimated $168K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in RETA in Q2 2020 and held it in 6 quarters. The position peaked at $1.46M in Q4 2020. 205 funds tracked by Wall St. Rank hold RETA as of Q1 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 4,414 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2023, an estimated $168K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2020 and held it in 6 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.46M in Q4 2020.
  • 205 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.